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Abstract
Objective—To describe common facilitators, challenges, and lessons learned of five schools and 
colleges of pharmacy in establishing community pharmacy research fellowships.
Setting—Five schools and colleges of pharmacy in the United States.
Practice Description—Schools and colleges of pharmacy with existing community 
partnerships identified a need and ability to develop opportunities for pharmacists to engage in 
advanced research training.
Practice Innovation—Community pharmacy fellowships, each structured as two years in length 
and in combination with graduate coursework, have been established at the University of 
Pittsburgh, Purdue University, East Tennessee State University, University of North Carolina at 
Chapel Hill and The Ohio State University.
Evaluation—Program directors from each of the five community pharmacy research fellowships 
identified common themes pertaining to program structure, outcomes, and lessons learned to assist 
others planning similar programs.
Results—Common characteristics across the programs include length of training, pre-requisites, 
graduate coursework, mentoring structure, and immersion into a pharmacist patient care practice. 
Common facilitators have been the existence of strong community pharmacy partnerships, creating 
a fellowship advisory team, and networking. A common challenge has been recruitment, with 
many programs experiencing at least one year without filling the fellowship position. All program 
graduates (n=4) have been successful in securing pharmacy faculty positions.
Conclusion—Five schools and colleges of pharmacy share similar experiences in implementing 
community pharmacy research fellowships. Early outcomes show promise for this training 
pathway in growing future pharmacist-scientists focused on community pharmacy practice.
Keywords
Community pharmacy services; research; pharmacy education; fellowships and scholarships
INTRODUCTION
Poor patient outcomes, in spite of significant spending on healthcare, remain a pervasive 
challenge for the United States.1 Recent efforts have focused on the development and 
evaluation of new community care delivery models to improve outcomes and significant 
federal funding has been allocated for this work.2 Moreover, legislative efforts are underway 
to address the 2010 report to the US Surgeon General’s, “Improving Patient and Health 
System Outcomes Through Advanced Pharmacy Practice,” call for pharmacists’ recognition 
as health care providers in the Social Security Act.3 Much attention has been paid recently to 
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the role pharmacists play in primary care, prevention, public health, and care coordination. 
Engaging pharmacist-scientists in these efforts may help to achieve these goals. This is 
especially important for pharmacists practicing in the community where there is great need 
to implement and evaluate new patient care models and their impact on patient outcomes. 
This is furthered evidenced by the Medicare Prescription Drug Improvement and 
Modernization Act, which created Medicare Part D and required that prescription drug plans 
provide coverage for medication therapy management (MTM) services in 2006, yet wide-
scale implementation in community pharmacies has not yet been achieved.4
The demand for pharmacist-scientists capable of contributing meaningfully to scholarship 
and teaching has increased, in part due to the numerous new schools and colleges of 
pharmacy that have opened in recent years.5 Therefore, producing pharmacist faculty trained 
in research is critical for filling an ever-widening gap that exists both in science and 
pharmacy education. Although the National Institutes of Health (NIH) supports the notion of 
pharmacists serving in this role, much work is needed to position more pharmacists as 
leaders in research.6 A 2010 evaluation of junior pharmacy practice faculty found that fewer 
than half of the respondents felt comfortable with initiating a research project. Respondents’ 
top two areas of interest for further training were in managing funding issues and statistical 
analysis.7 Community pharmacy residency graduates also feel unprepared for faculty roles, 
particularly in regard to the research component of these positions.8 While residency 
projects have been reported to add value, relatively few are ultimately published.9–11 As the 
majority of pharmacy graduates are entering positions in community practice, there is a need 
for strong academic leaders focused on the growth and success of community pharmacy 
practice.12
One solution for furthering pharmacist research skills is the completion of postgraduate 
fellowship programs. The American College of Clinical Pharmacy (ACCP) supports 
fellowship training as one option.13 ACCP also has guidelines for fellowship training and a 
process by which fellowship programs can undergo peer review in order to be recognized as 
a fellowship that meets ACCP guidelines.
Fellowship programs focusing uniquely on research surrounding community pharmacist-
delivered care and the development of community pharmacy faculty may serve as a pivotal 
strategy for meeting the needs of science and the profession.
OBJECTIVE
The purpose of this paper is to describe common facilitators, challenges, and lessons learned 
of five schools and colleges of pharmacy in establishing community pharmacy research 
fellowships, which may assist others working to establish community pharmacy research 
fellowships at their institutions.
SETTING
This paper shares the experiences of the University of Pittsburgh School of Pharmacy, 
Purdue University College of Pharmacy, East Tennessee State University College of 
Pharmacy, University of North Carolina Eshelman School of Pharmacy, and The Ohio State 
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University College of Pharmacy. Each of these Schools/Colleges has established a 
postgraduate fellowship program for pharmacists interested in advancing community 
pharmacist practice through research. To our knowledge, these programs represent all active 
community pharmacy fellowship programs in the United States.
PRACTICE INNOVATION
This paper describes an innovation in practice-based research training for pharmacists 
through creation of the community pharmacy research fellowship model. The purpose of 
community pharmacy research fellowship training is to grow future leaders in community 
pharmacy research. As described in the ACCP Guidelines for Clinical Research Fellowship 
Programs, whereas residency training is focused on developing expertise in practice with 
some experience with research and teaching, fellowship training is focused on developing 
expertise in research with some experience in teaching and practice. Fellowships are 
generally highly individualized training programs approximately two years in length and 
combined with graduate coursework. Therefore, specific goals and features of programs vary 
by institution. The programs include a practice component for the fellows as a mechanism 
by which fellows can maintain competency as a clinician, identify relevant research 
questions, and foster collaborations and educational opportunities with practitioners as well 
as students/residents.
To our knowledge, the genesis of community pharmacy research fellowship training in the 
United States was at the University of Pittsburgh. In 2007, the School established the 
fellowship as an opportunity to more formally grow community pharmacy-based research 
and meet national needs for such research and appropriately trained individuals. The 
fellowship complemented existing community-based programs at the School, including the 
PGY-1 community pharmacy residency, which launched in 2006. Early experiences with the 
fellowship were briefly described previously.14
The University of Pittsburgh’s first fellow completed the program in 2009 and joined the 
faculty at Purdue University. As part of this faculty position, a residency program was 
planned and funding committed. After discussion with the Department Head and Dean, 
approval was received to modify the residency to become a two-year fellowship program 
modeled after the program at the University of Pittsburgh. In the subsequent years, similar 
programs have emerged at East Tennessee State University, the University of North 
Carolina, and The Ohio State University. The requirements and key features of these five 
community pharmacy research fellowship programs are described in greater detail in Tables 
1 and 2.
EVALUATION/RESULTS
Below, we share early program outcomes as well as common experiences pertaining to the 
challenges we have experienced, facilitators to successful implementation, and lessons 
learned.
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Outcomes for Programs with Graduates
Thus far, the five programs described have produced four graduates (two graduates from the 
University of Pittsburgh and two graduates from Purdue University). Upon graduation, 
fellows were offered positions including research scientist positions, tenure-track faculty 
positions, and practice faculty positions. Positions accepted included tenure-track positions 
(n=2) and practice faculty positions with significant research effort (n=2). Across the four 
graduates, a total of 39 abstracts were accepted during fellowship and 25 peer-reviewed 
publications resulted from work completed during fellowship. Since graduation, the four 
graduates have accumulated a total of six research grants or contracts as Principal 
Investigator, totaling $734,589.
Experiences and Lessons Learned
Building off Existing Programs and Partnerships—Each of these five fellowship 
programs build off of other College community-based partnerships and/or existing residency 
and graduate programs. The maturity of these existing programs creates a strong 
environment for launching the fellowship. Common elements have included current PGY-1 
community pharmacy residency programs, practice-based research networks (PBRNs), 
community pharmacy-focused research initiatives, and existing MS or MPH programs. 
Capitalizing on these existing partnerships has been invaluable in identifying prospective 
candidates, practice and research opportunities for the fellows, and appropriate preceptors 
and mentors. These partnerships have also created natural teaching opportunities for the 
fellows. Across our programs, the fellows work or will work closely, with PGY-1 
community pharmacy residents and faculty members. Fellows are able to develop teaching 
skills through providing mentorship on residency research projects as well as clinical 
teaching opportunities through precepting residents.
Importance of Creating a Fellowship Team—In all of these programs, fellows receive 
mentorship from a group of formal and informal preceptors rather than only an individual 
fellowship director. This approach has been successful in allowing the fellow to benefit from 
multiple strengths, talents, and experiences. At minimum, this has included both a 
fellowship director(s)/research mentors along with a practice preceptor to oversee the patient 
care component of the fellowship. Some programs have formed a fellowship council or 
committee as well. Involving multiple preceptors enables the fellows to learn from others 
with expertise in specific areas of focus for the program, including research, teaching, and 
patient care, and introduces the fellow to new content areas and additional opportunities for 
professional growth.
Flexibility in Graduate Program Requirement—While all of our programs include 
the completion of graduate coursework as part of the fellowship, this requirement is tailored 
in unique ways to meet the local needs of each fellowship (Table 3). For example, at the 
University of Pittsburgh, the fellow completes an MPH degree, which is also an option at 
East Tennessee State University. ETSU also offers a graduate certificate in biostatistics, 
epidemiology, and health care management if the MPH degree is not desired. At the 
University of North Carolina, the fellow enrolls in courses through the Translational and 
Clinical Research Curriculum, created through an NIH Clinical and Translational Science 
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Award. Alternatively, at Purdue University, the fellows enroll in the College’s graduate 
program and complete an MS degree. The graduate programs range from 18–45 credits and 
include both thesis and non-thesis options. Regardless of the specific degree completed, we 
have found that this portion of the fellowship is critical in developing specific research skills 
(e.g., research methods, statistics) while gaining “hands on” research experience through 
their fellowship projects.
Shared Learning and Networking Opportunities—Each of our programs have 
benefited from shared learning and networking with each other and colleagues external to 
the programs. Informal means of communication across existing programs have been 
utilized, as current programs have developed from existing personal relationships. Emails, 
impromptu gatherings at professional meetings and conference calls have been used to 
network and share ideas. The growing network of community pharmacy residency programs 
and directors has been another beneficial source of ideas. As the need for community 
pharmacy fellowship-trained individuals increases in the future, we suspect that the number 
of available positions will also increase, leading to a need for more formal and structured 
communications.
Placement of Fellowship Graduates—Although collectively we have only graduated 
four fellows to date, we have found that the positions fellows were offered and ultimately 
pursued, aligned well with the goals of the programs and meet identified needs. Each of the 
four graduates accepted faculty positions and has either secured, or is actively pursuing, 
extramural funding for their research programs. This gives us confidence in the ongoing 
success of these programs and their ability to fill a gap in the development of community-
focused researchers.
Recruitment—Recruiting appropriate candidates has been the greatest challenge that we 
have observed. Two of our programs have experienced years in which appropriate candidates 
were not identified and positions were left unfilled. However, from our experiences we have 
also identified recruitment approaches that work well and that others seeking to establish 
similar programs may wish to consider. First, we have seen that recruitment needs to involve 
several avenues that incorporate both active information dissemination and candidate 
searches. Our programs include information about the fellowship on our institutions’ 
websites, and have found it is important to keep such information up to date for program 
recognition. Furthermore, most programs have attended the American Society of Health-
System Pharmacists (ASHP) Midyear Clinical Meeting and utilized the Personal Placement 
Service (PPS) for completing initial interviews with interested candidates. While PPS has 
been a valuable tool, it may be necessary for program directors to be proactive in identifying 
candidates for interviews. As current PGY-1 residents may be unaware that fellowship 
training is an option, some of our programs have found it valuable to contact those residents 
expressing interest in faculty positions, particularly in community or ambulatory care (via 
their PPS profile) in order to describe the fellowship and ways in which the training could 
better position the candidate for the faculty position desired.
In addition to our websites and PPS, our programs have recruited candidates at the American 
Pharmacists Association (APhA) Professional Opportunities Connection, and American 
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College of Clinical Pharmacy (ACCP) Residency and Fellowship Forum at their annual 
meetings, and included information about the programs in the ACCP Directory of 
Residencies, Fellowships, and Graduate Programs. Reaching out to PGY-1 community 
pharmacy residency program directors and sending personal emails to current community 
pharmacy residents or other colleagues has also been utilized.
Finally, we have found that it is important to be confident in the admissions requirements but 
with a degree of flexibility. For example, many PharmD students have expressed interest in 
entering the fellowships immediately after graduation. However, four of our programs 
require completion of a PGY-1 community pharmacy residency or equivalent practice 
experience, because of the program goals of creating pharmacist-scientists with patient care 
experience and their role in overseeing practice activities of PGY-1 community residents.
DISCUSSION
The need for pharmacist-scientists versed in community pharmacy practice has prompted the 
development of fellowships focused on community pharmacy research at multiple academic 
institutions. As described, the programs are modeled after the ACCP fellowship guidelines 
and have similar core characteristics in terms of the approach to mentorship, prerequisites, 
program length, and overall structure. Moreover, although ACCP does not recommend a 
specific number of credit hours devoted to biostatistics and/or research methods, the 
inclusion of graduate coursework on these topics in each of these fellowship programs aligns 
well with ACCP recommendations.14 ACCP recommendations also do not specify whether 
completion of a thesis would be considered more desirable than a non-thesis degree; rather, 
the recommendations emphasize research and grantsmanship skill obtainment that could be 
achieved in a number of ways. This flexibility has been embraced by the community 
fellowships, contributing to the individualized nature and, consequently, natural variability in 
graduate coursework structure across these programs.
Recruitment has been the primary challenge shared among the fellowship programs possibly 
due to a lack of awareness of community pharmacy fellowships, uncertainty regarding 
employment options post-fellowship, and an overall lack of understanding of program goals. 
Prior research has measured the financial implications for pharmacists choosing to pursue 
graduate school and determined that financial incentives need to be improved in order to 
successfully encourage PharmD graduates to consider obtaining a PhD.16 As community 
pharmacy fellowships require a minimum of three years post-PharmD to complete and 
fellowship graduates are likely to pursue similar positions as PhD graduates, it is likely that 
the same is true for these programs. Changes in the pharmacy workforce and demand for 
pharmacists are other factors that could influence recruitment. In addition to changes in the 
workforce, the overall health system shift to outcomes and value-based care will likely lead 
to demand for pharmacists with the skills needed to conduct practice-based research in 
community settings.
Recruitment may become less of a challenge in the future, as overall acceptance and 
awareness of community pharmacy fellowships grows, and as more attention is given to the 
importance of research in the PharmD curriculum.17 Pharmacy residencies of every type 
Snyder et al. Page 7
J Am Pharm Assoc (2003). Author manuscript; available in PMC 2017 July 31.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
faced similar recruitment challenges in their early stages, but as the healthcare landscape has 
shifted, there are currently far more applicants for residencies than available positions.18 It is 
reasonable to predict that as change continues, graduates will increasingly seek new 
postgraduate opportunities to prepare them for challenges ahead. This has been evidenced by 
a growing emphasis on discussion regarding innovative training models for community 
pharmacists during special sessions at the APhA Annual Meeting and Exposition over the 
past few years. At these meetings, community pharmacy fellowship training as well as 
emerging PGY-2 community pharmacy residencies have been discussed.19–20
As with the growth of pharmacy residency training, as community pharmacy fellowships 
multiply, formality in accreditation or other recognition of quality may be developed. 
Currently, research fellowship program review has been limited to the voluntary ACCP Peer 
Review of Fellowships, which defines requirements for the training program, preceptor 
quality, fellowship applicant criteria, and fellowship experiences.14 As ASHP and APhA 
currently jointly accredit community pharmacy residencies,21 perhaps joint accreditation and 
peer review of fellowship programs by ACCP and APhA will one day be considered. As 
programs continue to expand geographically and strengthen, a more formalized process and 
resource center may assist programs to continue to grow while assuring quality of 
experience for all fellows.
CONCLUSION
Development and initial success of these five community pharmacy fellowship programs has 
led to community-focused pharmacist-scientists prepared for academic roles. The continued 
growth and development of these programs will help address the need for successful 
pharmacist-scientists who contribute meaningfully to community pharmacy practice 
research, education, and innovation. We hope sharing these lessons learned and experiences 
will assist additional institutions in implementing community pharmacy fellowships, and 
inform community pharmacy organizations of the potential to partner with trainees and their 
teams on meaningful and pragmatic community pharmacy research.
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KEY POINTS
What is already known
• New models of healthcare in the US are on the rise and community 
pharmacists play increasingly engaged roles in patient care.
• Due to community pharmacists’ rapidly expanding engagement in patient 
care, there is a need for pharmacist-scientists and pharmacy faculty with 
expertise in community-focused research to advance, replicate and scale 
pharmacist-provided care in the community.
What the findings add
• Community pharmacy research fellowships have been established 
successfully at five academic institutions using common strategies while 
facing similar challenges.
• Fellowship graduates have been successful in publishing peer-reviewed 
articles, securing grant funding, and securing faculty positions.
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